meclofenamic acid has been researched along with Brain Neoplasms in 4 studies
Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
Excerpt | Relevance | Reference |
---|---|---|
" The orally bioavailable modulators of gap junctions meclofenamate and tonabersat break this paracrine loop, and we provide proof-of-principle that these drugs could be used to treat established brain metastasis." | 1.43 | Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. ( Boire, A; Chen, Q; Cross, JR; Er, EE; Jacob, L; Jin, X; Lopez-Soto, A; Massagué, J; Patwa, R; Shah, H; Valiente, M; Xu, K, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Xiao, L | 1 |
Li, X | 1 |
Mu, Z | 1 |
Zhou, J | 1 |
Zhou, P | 1 |
Xie, C | 1 |
Jiang, S | 1 |
Schneider, M | 1 |
Vollmer, L | 1 |
Potthoff, AL | 1 |
Ravi, VM | 1 |
Evert, BO | 1 |
Rahman, MA | 1 |
Sarowar, S | 1 |
Kueckelhaus, J | 1 |
Will, P | 1 |
Zurhorst, D | 1 |
Joseph, K | 1 |
Maier, JP | 1 |
Neidert, N | 1 |
d'Errico, P | 1 |
Meyer-Luehmann, M | 1 |
Hofmann, UG | 1 |
Dolf, A | 1 |
Salomoni, P | 1 |
Güresir, E | 1 |
Enger, PØ | 1 |
Chekenya, M | 1 |
Pietsch, T | 1 |
Schuss, P | 1 |
Schnell, O | 1 |
Westhoff, MA | 1 |
Beck, J | 1 |
Vatter, H | 1 |
Waha, A | 1 |
Herrlinger, U | 1 |
Heiland, DH | 1 |
Chen, Q | 1 |
Boire, A | 1 |
Jin, X | 1 |
Valiente, M | 1 |
Er, EE | 1 |
Lopez-Soto, A | 1 |
Jacob, L | 1 |
Patwa, R | 1 |
Shah, H | 1 |
Xu, K | 1 |
Cross, JR | 1 |
Massagué, J | 1 |
Cui, Q | 1 |
Shi, H | 1 |
Ye, P | 1 |
Li, L | 1 |
Qu, Q | 1 |
Sun, G | 2 |
Lu, Z | 1 |
Huang, Y | 1 |
Yang, CG | 1 |
Riggs, AD | 1 |
He, C | 1 |
Shi, Y | 1 |
4 other studies available for meclofenamic acid and Brain Neoplasms
Article | Year |
---|---|
FTO Inhibition Enhances the Antitumor Effect of Temozolomide by Targeting MYC-miR-155/23a Cluster-MXI1 Feedback Circuit in Glioma.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Antineoplastic Agents, Alkylating; Basic Hel | 2020 |
Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastoma.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; In Vitro Techniques; Me | 2021 |
Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer.
Topics: Animals; Astrocytes; Benzamides; Benzopyrans; Brain Neoplasms; Breast Neoplasms; Cadherins; Cell Lin | 2016 |
m
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Base Sequence; Brain Neoplasms; C | 2017 |